Castleman disease is one of those medical terms that sounds like it belongs in a fantasy novel, perhaps guarded by a dragon and a very serious wizard. In reality, it is a rare group of lymph node disorders that can range from a single enlarged lymph node to a body-wide inflammatory illness. Because it is uncommon and can look like infections, autoimmune diseases, or lymphoma, Castleman disease often requires careful testing and a team that knows how to connect the dots.
The two major forms are unicentric Castleman disease and multicentric Castleman disease. The names are surprisingly helpful: “uni” means one area, while “multi” means multiple areas. But the differences go much deeper than geography. These two forms can differ in symptoms, causes, treatment, monitoring, and long-term outlook.
This guide explains what Castleman disease is, how unicentric and multicentric disease compare, what symptoms may appear, how doctors diagnose it, and what treatment may involve. It is written for readers who want a clear, practical explanation without needing a medical dictionary in one hand and a gallon of coffee in the other.
Note: This article is for educational purposes only and should not replace medical advice from a qualified health care professional.
What Is Castleman Disease?
Castleman disease is a rare lymphoproliferative disorder, meaning it involves an abnormal overgrowth of cells in lymph nodes and related immune tissues. Lymph nodes are small immune-system “checkpoints” found throughout the body. They help filter lymph fluid, house immune cells, and respond to infections. When lymph nodes enlarge, it may be due to something ordinary, like a cold, or something more complex, like an immune disorder, cancer, or Castleman disease.
Castleman disease is not exactly one single disease. It is better understood as a group of related conditions that share certain lymph node changes under the microscope. Some cases are localized and can be treated successfully with surgery. Others are systemic, meaning they involve widespread inflammation and may require long-term medical therapy.
The condition was first described by Dr. Benjamin Castleman in the 1950s. Since then, researchers have learned that Castleman disease can behave very differently from one person to another. That is why understanding the type matters so much.
Unicentric vs. Multicentric Castleman Disease: The Big Difference
The simplest way to separate the two major types is by asking one question: How many lymph node regions are involved?
Unicentric Castleman Disease
Unicentric Castleman disease, often shortened to UCD, affects a single lymph node region. This may mean one enlarged lymph node or a cluster of nearby lymph nodes in one area of the body. Common locations include the chest, abdomen, neck, pelvis, or underarm.
Many people with UCD do not have dramatic symptoms. In fact, some cases are discovered by accident during imaging for another issue. A person might have a CT scan for abdominal discomfort, a chest scan after an unrelated concern, or surgery for another reason, and suddenly a suspicious enlarged lymph node appears on the medical radar.
When symptoms do occur, they often come from pressure caused by the enlarged lymph node. For example, a lymph node in the chest may cause cough, chest discomfort, or breathing-related symptoms. One in the abdomen may cause fullness, pain, or digestive complaints. Some people may also experience fatigue, fever, night sweats, or weight loss, especially if the tissue pattern is more inflammatory.
Multicentric Castleman Disease
Multicentric Castleman disease, or MCD, affects multiple lymph node regions and may involve systemic inflammation. Instead of one neighborhood causing trouble, the immune system starts acting like the entire city has an emergency alert. People with MCD may have enlarged lymph nodes in several areas, fever, night sweats, fatigue, appetite loss, weight loss, swelling, anemia, low platelets, enlarged liver or spleen, and abnormal blood markers of inflammation.
MCD is usually more serious than UCD because it can affect the whole body. It may require treatment from specialists such as hematologists, oncologists, infectious disease experts, or immunologists. In severe cases, organ function may be affected, so timely diagnosis and treatment are important.
Types of Multicentric Castleman Disease
Multicentric Castleman disease is usually divided into categories based on what appears to be driving the immune overactivity.
HHV-8-Associated Multicentric Castleman Disease
Some cases of MCD are associated with human herpesvirus 8, also called HHV-8 or Kaposi sarcoma-associated herpesvirus. This form is more common in people with weakened immune systems, including some people living with HIV. HHV-8 can stimulate immune signaling pathways and contribute to the overgrowth of lymph node cells.
Idiopathic Multicentric Castleman Disease
When MCD is not linked to HHV-8, it may be called idiopathic multicentric Castleman disease, or iMCD. “Idiopathic” is medical language for “we do not yet know the exact cause,” which is both honest and mildly unsatisfying. Researchers believe that abnormal immune activation and inflammatory proteins, especially interleukin-6, may play an important role in many cases.
POEMS-Associated Castleman Disease
Castleman-like lymph node changes may also appear in association with POEMS syndrome, a rare disorder involving nerve problems, organ enlargement, hormone changes, abnormal blood proteins, and skin changes. Because POEMS has its own underlying disease process, doctors usually evaluate it separately from idiopathic MCD.
Common Symptoms of Castleman Disease
Symptoms depend heavily on the type of Castleman disease, the location of affected lymph nodes, and the level of inflammation in the body.
Possible Symptoms of Unicentric Castleman Disease
Unicentric disease may cause no symptoms at all. When symptoms appear, they may include a lump or swelling in one area, chest or abdominal pressure, cough, trouble swallowing, discomfort, or pain near the affected lymph node. Some people experience general symptoms such as tiredness, low fever, or night sweats, but these are less common than in multicentric disease.
Possible Symptoms of Multicentric Castleman Disease
Multicentric disease is more likely to cause whole-body symptoms. These can include persistent fever, drenching night sweats, severe fatigue, unexplained weight loss, appetite changes, swollen lymph nodes in several areas, swelling in the legs or abdomen, enlarged spleen or liver, anemia, abnormal blood counts, and high inflammatory markers.
Because these symptoms can overlap with lymphoma, autoimmune disease, chronic infections, and other inflammatory disorders, Castleman disease is sometimes called a “great imitator.” It does not walk into the doctor’s office wearing a name tag. Diagnosis usually takes careful investigation.
What Causes Castleman Disease?
The cause depends on the subtype. In unicentric Castleman disease, the exact cause is often unknown. Most cases appear localized, and many patients do well after complete surgical removal of the affected lymph node region.
In HHV-8-associated multicentric Castleman disease, the virus plays a major role. In idiopathic multicentric Castleman disease, researchers suspect abnormal immune system activation, inflammatory cytokines, and disrupted immune signaling. Interleukin-6, often shortened to IL-6, is especially important because it can drive inflammation, fever, anemia, and lymph node cell growth.
Castleman disease is not considered contagious in the way a cold or flu is contagious. A person does not “catch” unicentric or idiopathic multicentric Castleman disease from casual contact. However, HHV-8 itself is a virus, and doctors may test for it when evaluating MCD.
How Castleman Disease Is Diagnosed
Diagnosis usually requires several steps. Doctors often begin with a physical exam and medical history, then order blood tests, imaging, and ultimately a lymph node biopsy.
Blood and Urine Tests
Blood tests may check for anemia, platelet changes, kidney or liver involvement, inflammation markers such as C-reactive protein, abnormal proteins, and signs of infection. These tests do not diagnose Castleman disease by themselves, but they help reveal the pattern of illness and rule out other conditions.
Imaging Tests
CT scans, PET scans, MRI, or ultrasound may be used to find enlarged lymph nodes and determine whether the disease appears localized or multicentric. Imaging also helps guide biopsy planning and treatment decisions.
Lymph Node Biopsy
A biopsy is essential. A pathologist examines lymph node tissue under a microscope to look for Castleman disease patterns and to rule out lymphoma and other causes of lymph node enlargement. Whenever possible, doctors may prefer an excisional biopsy, meaning the whole lymph node or a large enough piece is removed for detailed evaluation.
Because Castleman disease is rare, a second pathology review by an experienced center may be helpful. In rare diseases, getting the right label matters. A misdiagnosis can send treatment down the wrong road, and nobody wants the immune-system version of taking the wrong exit for 80 miles.
Treatment for Unicentric Castleman Disease
The main treatment for unicentric Castleman disease is surgical removal of the affected lymph node or lymph node region. When complete removal is possible, many patients are considered cured, especially if symptoms and lab abnormalities resolve afterward.
If the lymph node is in an easy-to-reach area, surgery may be straightforward. If it is deep in the chest or abdomen, surgery can be more complex and may require a specialized surgical team. The location, size, blood vessel involvement, and surrounding organs all influence the plan.
When surgery is not immediately possible, doctors may consider other treatments to shrink the mass or control symptoms. These may include corticosteroids, rituximab, anti-inflammatory therapy, radiation in selected cases, or other approaches depending on the patient’s situation. The goal is often to make surgery safer or manage symptoms when surgery is too risky.
After treatment, follow-up imaging and blood tests may be recommended. Even when the outlook is excellent, monitoring helps confirm that the disease remains controlled.
Treatment for Multicentric Castleman Disease
Multicentric Castleman disease requires systemic treatment because the problem is not limited to one lymph node region. The treatment depends on the subtype, severity, symptoms, lab results, organ involvement, and whether HHV-8 or HIV is present.
Treatment for HHV-8-Associated MCD
HHV-8-associated MCD is often treated with therapies that target abnormal B cells, such as rituximab. In people with HIV, effective antiretroviral therapy is also important. Additional treatment may be needed depending on severity and related conditions.
Treatment for Idiopathic MCD
For idiopathic multicentric Castleman disease, IL-6-directed therapy is a major treatment strategy. Siltuximab, a monoclonal antibody that targets IL-6, is commonly recommended as a first-line therapy for many patients with iMCD. Tocilizumab, which targets the IL-6 receptor, may be considered in settings where siltuximab is not available or appropriate.
Some patients may need corticosteroids, immunosuppressive medications, rituximab, chemotherapy, antivirals, or other targeted treatments. Severe iMCD can progress quickly, so doctors may act aggressively when there are signs of organ dysfunction, severe inflammation, or life-threatening complications.
Living With Castleman Disease
Living with Castleman disease can feel confusing because the condition is rare, the vocabulary is intimidating, and many people have never heard of it. Patients may go through multiple appointments before getting a clear diagnosis. That uncertainty can be exhausting.
A helpful first step is learning the exact subtype. “Castleman disease” alone is not specific enough. Patients should know whether they have unicentric disease, HHV-8-associated MCD, idiopathic MCD, or Castleman-like changes related to another condition. That information shapes treatment and follow-up.
It is also useful to keep copies of biopsy reports, imaging results, lab trends, medication lists, and specialist notes. Rare disease care often involves several doctors, and organized records can save time, reduce confusion, and help new providers understand the case faster.
Questions to Ask Your Doctor
Good questions can make appointments more productive. Consider asking:
- Which type of Castleman disease do I have?
- Is my disease unicentric or multicentric?
- Were HHV-8, HIV, lymphoma, autoimmune disease, and infection evaluated?
- Do I need a second pathology review?
- Is surgery possible in my case?
- Which blood markers should be monitored?
- What symptoms should prompt urgent medical attention?
- How often should I have follow-up imaging or lab testing?
- Are there clinical trials or specialty centers I should know about?
Real-World Experiences: What Patients and Families Often Notice
Experiences with Castleman disease can vary widely, but many patients describe one shared theme: the road to diagnosis is rarely a straight line. A person with unicentric disease may feel perfectly healthy until an imaging scan finds a mass in the chest or abdomen. The discovery can be alarming because enlarged lymph nodes raise scary possibilities. Then comes the waiting: more scans, a biopsy, pathology results, maybe a second opinion. Even when the final diagnosis is treatable, the emotional suspense can feel like being stuck in a medical mystery series where every episode ends on a cliffhanger.
For people with unicentric Castleman disease, surgery can be both frightening and hopeful. Some patients hear that complete removal may be curative, which is encouraging, but the location of the lymph node matters. A small node near the neck may be easier to remove than a mass wrapped near important blood vessels in the chest or abdomen. Families often focus on practical details: which surgeon has experience, how long recovery may take, whether symptoms will improve, and what follow-up will look like. After successful surgery, many people describe relief mixed with a new awareness of their health. They may still feel nervous before follow-up scans, which is completely understandable.
Multicentric Castleman disease can create a different experience because symptoms may be widespread and unpredictable. Patients may feel exhausted, feverish, swollen, or generally unwell without knowing why. Some are first evaluated for infection, autoimmune disease, or lymphoma. When the answer turns out to be MCD, it can be validating and overwhelming at the same time. Having a name for the illness helps, but the treatment plan may involve infusions, blood monitoring, infection precautions, and ongoing specialist care.
Families often become record-keepers and advocates. They track fevers, weight changes, swelling, medications, lab numbers, and appointment questions. This may sound ordinary, but in rare disease care, organization can be powerful. A well-kept folder or digital file can help doctors see trends more clearly. It can also reduce the stress of repeating the same medical story at every visit.
Another common experience is the challenge of explaining Castleman disease to others. Because it is rare, patients may hear, “Castle-what?” more times than they can count. A simple explanation helps: “It is a rare lymph node disorder. Mine is localized,” or “Mine affects multiple lymph node areas and causes immune inflammation.” Clear language can make conversations with employers, teachers, friends, and relatives less exhausting.
Emotionally, people may move between fear, frustration, hope, and determination. That is normal. Rare disease patients often benefit from support groups, reliable educational resources, and medical teams that take symptoms seriously. The most reassuring message is this: Castleman disease is complex, but it is increasingly understood. Research has improved diagnosis and treatment, and many patients do well with the right plan and follow-up.
Conclusion
Understanding unicentric and multicentric Castleman disease starts with recognizing that these are related but very different conditions. Unicentric Castleman disease usually affects one lymph node region and is often treated successfully with surgery. Multicentric Castleman disease affects multiple regions and can cause body-wide inflammation, requiring systemic treatment and careful monitoring.
Because Castleman disease is rare and can mimic many other illnesses, diagnosis often depends on a combination of imaging, blood tests, biopsy, and expert review. Treatment has improved as researchers have learned more about immune signaling, HHV-8, and IL-6-driven inflammation. For patients and families, the best approach is to learn the subtype, ask clear questions, keep good records, and work with clinicians familiar with rare lymph node disorders.
Castleman disease may have a dramatic name, but with accurate diagnosis, thoughtful care, and ongoing research, many people can move from confusion toward clarityand that is a plot twist worth cheering for.
